Literature DB >> 18794800

RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin.

V V Kurisetty1, P G Johnston, N Johnston, P Erwin, P Crowe, D G Fernig, F C Campbell, I P Anderson, P S Rudland, M K El-Tanani.   

Abstract

Osteopontin (OPN) is a phosphorylated glycoprotein that binds to alpha v-containing integrins and is important in malignant transformation and cancer. Previously, we have utilized suppressive subtractive hybridization between mRNAs isolated from the Rama 37 (R37) rat mammary cell line and a subclone rendered invasive and metastatic by stable transfection with an expression vector for OPN to identify RAN GTPase (RAN) as the most overexpressed gene, in addition to that of OPN. Here we show that transfection of noninvasive R37 cells with an expression vector for RAN resulted in increased anchorage-independent growth, cell attachment and invasion through Matrigel in vitro, and metastasis in syngeneic rats. This induction of a malignant phenotype was induced independently of the expression of OPN, and was reversed by specifically reducing the expression of RAN using small-interfering RNAs. By using a combination of mutant protein and inhibitors, it was found that RAN signal transduction occurred through the c-Met receptor and PI3 kinase. This study therefore identifies RAN as a novel effector of OPN-mediated malignant transformation and some of its downstream signaling events in a mammary epithelial model of cancer invasion/metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794800     DOI: 10.1038/onc.2008.325

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

Review 1.  Role of osteopontin in the pathophysiology of cancer.

Authors:  Lalita A Shevde; Rajeev S Samant
Journal:  Matrix Biol       Date:  2014-03-19       Impact factor: 11.583

Review 2.  Nanoparticulate RNA delivery systems in cancer.

Authors:  Ankur Sharma; Niraj Kumar Jha; Kajal Dahiya; Vivek Kumar Singh; Kundan Chaurasiya; Aditya Narayan Jha; Saurabh Kumar Jha; Prabhu Chandra Mishra; Sunny Dholpuria; Rani Astya; Parma Nand; Amit Kumar; Janne Ruokolainen; Kavindra Kumar Kesari
Journal:  Cancer Rep (Hoboken)       Date:  2020-07-30

3.  Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the expression of AR and CXCR4.

Authors:  Lin Deng; Yulong Shang; Shikong Guo; Changhao Liu; Lin Zhou; Yi Sun; Yongzhan Nie; Daiming Fan; Yuanyuan Lu; Xuegang Guo
Journal:  Cancer Biol Ther       Date:  2014-05-19       Impact factor: 4.742

4.  Identification of mTORC2 as a necessary component of HRG/ErbB2-dependent cellular transformation.

Authors:  Miao-chong J Lin; Katherine S Rojas; Richard A Cerione; Kristin F Wilson
Journal:  Mol Cancer Res       Date:  2014-03-10       Impact factor: 5.852

5.  Activation of the Ran GTPase is subject to growth factor regulation and can give rise to cellular transformation.

Authors:  Thi K Ly; Jianbin Wang; Ryan Pereira; Katherine S Rojas; Xu Peng; Qiyu Feng; Richard A Cerione; Kristin F Wilson
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

6.  Dietary vitamin D exposure prevents obesity-induced increase in endometrial cancer in Pten+/- mice.

Authors:  Wei Yu; Mark Cline; Larry G Maxwell; David Berrigan; Gustavo Rodriguez; Anni Warri; Leena Hilakivi-Clarke
Journal:  Cancer Prev Res (Phila)       Date:  2010-09-21

7.  RanGTPase: A Key Regulator of Nucleocytoplasmic Trafficking.

Authors:  Ki Lui; Ying Huang
Journal:  Mol Cell Pharmacol       Date:  2009

8.  Thioredoxin-like protein 2 is overexpressed in colon cancer and promotes cancer cell metastasis by interaction with ran.

Authors:  Yuanyuan Lu; Xiaodi Zhao; Kai Li; Guanhong Luo; Yongzhan Nie; Yongquan Shi; Yi Zhou; Gui Ren; Bin Feng; Zhenxiong Liu; Yan Pan; Ting Li; Xuegang Guo; Kaichun Wu; Antonio Miranda-Vizuete; Xin Wang; Daiming Fan
Journal:  Antioxid Redox Signal       Date:  2013-03-04       Impact factor: 8.401

9.  RAN GTPase and Osteopontin in Pancreatic Cancer.

Authors:  Shivam Saxena; Ankit Gandhi; Pei-Wen Lim; Daniel Relles; Konrad Sarosiek; Christopher Kang; Galina Chipitsyna; Jocelyn Sendecki; Charles J Yeo; Hwyda A Arafat
Journal:  Pancreat Disord Ther       Date:  2013-04-01

Review 10.  The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control.

Authors:  F C Campbell; Haibo Xu; M El-Tanani; P Crowe; V Bingham
Journal:  Biochem Pharmacol       Date:  2009-09-06       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.